There's no financial incentive for the pharmaceutical companies to support that, they have no indemnity risk, nor do the GPs. Tax payers are on the hook, but this is what you voted for, blame yourselves.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
